Back
Myriad Genetics Vs. Pro-Dex Industry Stock Comparison
Sell
28
MYGN
Myriad Genetics
Last Price:
$14.77
Seasonality Move:
3.46%
Buy
64
PDEX
Pro-Dex
Last Price:
$49.45
Seasonality Move:
2.59%
Sell
28
Myriad Genetics (MYGN)
is a Sell
Is Myriad Genetics a Buy, Sell or Hold?
-
The current Myriad Genetics [MYGN] share price is $14.78. The Score for MYGN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
MYGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MYGN Stock Price Chart
What is Myriad Genetics's stock price today?
-
The Myriad Genetics share price today is $14.78The current trend is relatively stagnant and MYGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
PDEX Stock Price Chart
MYGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 52.05 | Buy |
Chaikin Money Flow: | 525122 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.33 - 15.27) | Buy |
Bollinger Bands (100): | (15.37 - 26.73) | Sell |
PDEX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.21 | Buy |
Relative Strength Index (14 RSI): | 52.15 | Buy |
Chaikin Money Flow: | -24917 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.35 - 52.25) | Buy |
Bollinger Bands (100): | (24.83 - 47.33) | Buy |
MYGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.85 | Buy |
20-day SMA: | 13.91 | Buy |
50-day SMA: | 15.8 | Sell |
200-day SMA: | 22.25 | Sell |
8-day EMA: | 14.03 | Buy |
20-day EMA: | 14.24 | Buy |
50-day EMA: | 16.28 | Sell |
200-day EMA: | 20.68 | Sell |
PDEX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.35 | Buy |
20-day SMA: | 48.65 | Buy |
50-day SMA: | 46.23 | Buy |
200-day SMA: | 27.44 | Buy |
8-day EMA: | 50.04 | Sell |
20-day EMA: | 48.94 | Buy |
50-day EMA: | 45.04 | Buy |
200-day EMA: | 31.49 | Buy |
Myriad Genetics Earnings Growth & MYGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.29 per share.
Pro-Dex Earnings Growth & PDEX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and an increase next year of $0.06 per share.
Myriad Genetics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pro-Dex Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |